GeneMatrix Inc (109820) - Total Liabilities

Latest as of September 2025: ₩9.72 Billion KRW ≈ $6.59 Million USD

Based on the latest financial reports, GeneMatrix Inc (109820) has total liabilities worth ₩9.72 Billion KRW (≈ $6.59 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 109820 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

GeneMatrix Inc - Total Liabilities Trend (2011–2024)

This chart illustrates how GeneMatrix Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of GeneMatrix Inc.

GeneMatrix Inc Competitors by Total Liabilities

The table below lists competitors of GeneMatrix Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Rimfire Pacific Mining Ltd AU:RIM	Australia	AU$2.31 Million
ALUMEXX N.V. NAM. EO-10 F:NE8F	Germany	€32.15 Million
Eastparc Hotel Tbk PT JK:EAST	Indonesia	Rp24.07 Billion
Medipharm Labs Corp TO:LABS	Canada	CA$8.52 Million
VRX Silica Ltd AU:VRX	Australia	AU$761.02K
AJ Advance Technology Public Company Limited BK:AJA	Thailand	฿117.86 Million
BMS Celik Hasir Sanayi ve Ticaret AS IS:BMSCH	Turkey	TL869.65 Million
Flexiroam Ltd AU:FRX	Australia	AU$5.46 Million

Liability Composition Analysis (2011–2024)

This chart breaks down GeneMatrix Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 109820 net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.26	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.53	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.35	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how GeneMatrix Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for GeneMatrix Inc (2011–2024)

The table below shows the annual total liabilities of GeneMatrix Inc from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩9.23 Billion ≈ $6.26 Million	+12.49%
2023-12-31	₩8.21 Billion ≈ $5.56 Million	+6.34%
2022-12-31	₩7.72 Billion ≈ $5.23 Million	+7.01%
2021-12-31	₩7.21 Billion ≈ $4.89 Million	+51.02%
2020-12-31	₩4.78 Billion ≈ $3.24 Million	-63.84%
2019-12-31	₩13.21 Billion ≈ $8.95 Million	-36.15%
2018-12-31	₩20.68 Billion ≈ $14.02 Million	+209.45%
2017-12-31	₩6.68 Billion ≈ $4.53 Million	-2.43%
2016-12-31	₩6.85 Billion ≈ $4.64 Million	-36.24%
2015-12-31	₩10.74 Billion ≈ $7.28 Million	+108.13%
2014-12-31	₩5.16 Billion ≈ $3.50 Million	-25.15%
2013-12-31	₩6.90 Billion ≈ $4.67 Million	+7.29%
2012-12-31	₩6.43 Billion ≈ $4.36 Million	-6.58%
2011-12-31	₩6.88 Billion ≈ $4.66 Million	--

About GeneMatrix Inc

KQ:109820 Korea Diagnostics & Research

Market Cap

$21.51 Million

₩31.74 Billion KRW

Market Cap Rank

#24984 Global

#1816 in Korea

Share Price

₩1590.00

Change (1 day)

-0.31%

52-Week Range

₩1314.00 - ₩2975.00

All Time High

₩33900.00